Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2016 Sep 27;9(12):887–894. doi: 10.1158/1940-6207.CAPR-16-0124

Table 3.

Unanswered questions and future research

Epidemiology and Risk Factors
  • Population level incidence, prevalence, and trends using accurate classification and selection

  • Incidence and risk for dysplasia and colitis associated CRC with strictures, and identifying strictures associated with an increased risk for harboring dysplasia or colitis associated CRC

  • Incremental impact of having multiple risk factors present at baseline or over time

Molecular basis and targets of carcinogenesis
  • Whole exome sequencing of early dysplasia to understand sequence of genetic alterations

  • Predictive and prognostic importance of genetic alterations for progression to CRC

  • Targeted chemoprevention and personalized treatment of early dysplastic lesions with a particular emphasis on NF-kB inhibition, anti-interleukin and anti-cytokine biologics

Surveillance and Endoscopic Management
  • Risk stratified surveillance techniques and impact on disease outcomes

  • Non-invasive surveillance techniques (stool or blood based DNA testing)

  • Comparative effectiveness of enhanced visualization techniques